Chemomab Therapeutics Ltd...

NASDAQ: CMMB · Real-Time Price · USD
0.93
-0.01 (-1.06%)
At close: Aug 19, 2025, 3:59 PM
0.97
4.71%
Pre-market: Aug 20, 2025, 08:42 AM EDT

Chemomab Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13.95M -24.22M -27.65M -12.48M
Depreciation & Amortization
n/a 66.83K 58K 34K
Stock-Based Compensation
n/a 1.49M 3.21M 2.02M
Other Working Capital
-2.11M 222.52K 3.65M -3.12M
Other Non-Cash Items
670K -2.27K 2.96M 912.63K
Deferred Income Tax
n/a n/a -2.96M -912.63K
Change in Working Capital
-2.11M -945.56K 4.01M -1.95M
Operating Cash Flow
-15.39M -23.61M -20.37M -12.37M
Capital Expenditures
n/a -3K -68K -239K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -45.95M
Sales Maturities Of Investments
n/a n/a 19.6M n/a
Other Investing Acitivies
2.3M 15.88M 19.6M 1M
Investing Cash Flow
2.3M 15.88M 19.53M -45.19M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -1.22M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-46.84K 9.03K 143K 2.44M
Financial Cash Flow
9.87M 3.5M -808K 61.07M
Net Cash Flow
-3.22M -4.23M -1.65M 3.51M
Free Cash Flow
-15.39M -23.61M -20.44M -12.61M